Compare Organon Pharma Indonesia Tbk. (SCPI) vs Yanaprima Hastapersada Tbk (YPAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Yanaprima Hastapersada Tbk — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Yanaprima Hastapersada Tbk trades at Rp1,385 (market cap 808.28B, 383.7K 24h volume). The key difference: Yanaprima Hastapersada Tbk is far larger — about 7.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | YPAS | |
|---|---|---|
Market Cap | 104.4B | 808.28B |
Volume | — | 383.7K |
Lot | — | 3.84K |
Turnover | — | 504.87M |
Average Price | — | 1,315.78 |
Value | — | 504.87M |
Indicative Equilibrium Price | — | 1,385 |
Indicative Equilibrium Volume | — | 9 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Yanaprima Hastapersada Tbk
PT Yanaprima Hastapersada Tbk (the Company) was established in Indonesia based on Notarial Deed No. 38 of Emmy Hartati Yunizar, S.H., dated December 14, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 5 of Marina Soewana, S.H., dated Nov 1, 2007, concerning among others, the change of capital stucture, Company name and public offering.
Read more on YPAS →
